{
    "url_original": "https://www.wsj.com/articles/bausch-lomb-expected-to-price-ipo-at-low-end-or-below-targeted-range-11651770207?mod=markets_lead_pos10",
    "url": "bausch-lomb-expected-to-price-ipo-at-low-end-or-below-targeted-range-11651770207",
    "title": "Bausch + Lomb Expected to Price IPO at Low End or Below Targeted Range",
    "sub_head": "Eye-care company is set to test beleaguered new-issue market Friday",
    "category_1": "IPOs",
    "image_1_url": "https://images.wsj.net/im-535926?width=860&height=573",
    "image_1": "im-535926.jpg",
    "time": "2022-05-05 13:03:00",
    "body": "Bausch + Lomb Corp. is expected to price its IPO at the low end of expectations later Thursday in the latest sign of the challenges whipsawing stock prices pose for the new-issue market.<br />On Thursday, as the stock market tumbled, bankers on the deal told prospective investors the stock will likely be priced at the low end or below the targeted range of $21-to-$24 a share, according to people familiar with the matter. The company has been aiming to raise as much as $840 million ahead of its expected listing Friday, according to a regulatory filing."
}